The World Economic Forum report stresses that while gene therapies offer transformative potential for rare and inherited diseases, access remains uneven due to high costs, complex manufacturing, and limited regulatory alignment. It proposes a global framework focused on three pillars: innovative financing models, scalable manufacturing and supply chains, and international regulatory harmonization. Case studies highlight partnerships that improve affordability and accelerate approvals. By fostering collaboration among governments, industry, and patient groups, the report underscores that expanding equitable access to gene therapies can improve health outcomes and strengthen healthcare resilience worldwide.

Join for free to read